Radiological and functional pulmonary complications in patients recovered from COVID-19

Authors

DOI:

https://doi.org/10.54034/mic.e1217

Keywords:

COVID-19, SARS-CoV-2, lung effect, respiratory function test

Abstract

Background: The COVID-19 disease caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which appeared at the end of 2019 in Hubei Province, Wuhan Region of the People's Republic of China. Objective: To determine radiological and functional pulmonary complications in patients recovered from COVID-19. Methods: We included observational studies, studies of radiological and functional pulmonary complications related to COVID-19 in patients discharged from hospital, studies of available text and studies in English and Spanish. A formal narrative synthesis of the collected data was carried out; no formal statistical synthesis was carried out. The synthesis focused on qualitative analysis. The methodological quality of the articles was assessed using the quality assessment tools of the National Heart, Lung, and Blood Institute. Results: In this systematic review it was observed that the functional pulmonary complications that the patients manifested were: 45.05 % of impaired diffusion capacity (DLCO), 30.1 % of restrictive pattern (FEV1) and 20.4 % of obstructive pattern (FEV1/FVC). Radiological complications were: 59.7% ground-glass opacity (GGO), 18.75% consolidation, 9.3% bronchiectasis, 6% thickening of the underlying pleura, 3.9% thickening of the interlobular septum, 3.83% crazy-paving and 0.96% pleural effusion. Conclusion: This review concludes that post-COVID-19 infection patients showed impaired lung and radiological functions, with DLCO and GGO being the most important.

 

References

Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik Y, et al. Coronavirus disease 2019–COVID-19. Clinical Microbiology Reviews. 2020; 33(4): 1-48. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405836/

Organización Mundial de la Salud. Tablero COVID-19 [Internet]. Organización Mundial de la Salud; [citado el 07/05/2021]. Available at: https://covid19.who.int/

Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, et al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. 2020. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687368/

Venkataraman T, Frieman M. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Research. 2017; 143: 142-150. Available at: https://pubmed.ncbi.nlm.nih.gov/28390872/

Thomas M, Price O, Hull J. Pulmonary function and COVID-19. Current Opinion in Physiology. 2021. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997144/

Bellan M, Soddu D, Balbo P, Baricich A, Zeppegno P, Avanzi G, et al. Respiratory and psychophysical sequelae among patients with covid-19 four months after hospital discharge. JAMA Network Open. 2021 4(1): 2036142. Available at: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2775643

Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. European Respiratory Journal. 2020; 55(6): 2001217. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236826/

Yu M, Liu Y, Xu D, Zhang R, Lan L, Xu H. Prediction of the development of pulmonary fibrosis using serial thin-section ct and clinical features in patients discharged after treatment for COVID-19 pneumonia. Korean Journal of Radiology. 2020; 21(6): 746-755. Available at: https://pubmed.ncbi.nlm.nih.gov/32410413/

Sociedad Torácica Británica. Guía de la British Thoracic Society sobre el seguimiento respiratorio de pacientes con diagnóstico clínico-radiológico de neumonía COVID-19 [Internet]. 2020. Available at: https://www.brit-thoracic.org.uk/document-library/quality-improvement/covid-19/resp-follow-up-guidance-post-covid-pneumonia.

Urrutia G, Bonfill X. Declaración PRISMA: una propuesta para mejorar la publicacion de revisiones sistemáticas y metaanálisis. Med Clin. 2010; 135(11): 507-511. Available at: https://es.cochrane.org/sites/es.cochrane.org/files/public/uploads/PRISMA_Spanish.pdf

Instituto Nacional del Corazón, los Pulmones y la Sangre. Herramienta de losevaluación de la calidad para estudios observacionales de cohortes y transversales [Internet]. Instituto Nacional del Corazón, los Pulmones y la Sangre; [citado el 07 de mayo de 2021]. Available at: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.

Tú J, Zhang L, Ni-jia-Ti M, Zhang J, Hu F, Chen L, et al. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge. Journal of Infection. 2020; 81(2): 150-152. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273134/

Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respiratory Research. 2020; 21(1):163. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323373/

Zhao Y, Shang Y, Song W, Li Q, Xie H, Xu Q, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020; 25: 100463. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361108/

Liang L, Yang B, Jiang N, Fu W, He X, Zhou Y, et al. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. Journal of Korean Medical Science .2020; 35(46): 418. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721559/

Sociedad AT American Thoracic Society. Evaluacion de la deficiencia /discapacidad secundaria a trastornos respiratorios. Am Rev Respir Dis. 1986; 133(6): 1205-1209. Available at: https://pubmed.ncbi.nlm.nih.gov/3509148/

Wu Q, Zhong L, Li H, Guo J, Li Y, Hou X, et al. A Follow-Up Study of Lung Function and Chest Computed Tomography at 6 Months after Discharge in Patients with Coronavirus Disease 2019. Canadian Respiratory Journal. 2021; 2021. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881736/

Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, et al. Four-Month Clinical Status of a Cohort of Patients after Hospitalization for COVID-19. JAMA - Journal of the American Medical Association. 2021; 325(15): 1525-1534. Available at: https://jamanetwork.com/journals/jama/fullarticle/2777787

Van Gassel R, Bels J, Raafs A, van Bussel B, van de Poll M, Simons S, et al. High prevalence of pulmonary sequelae at 3 months after hospital discharge in mechanically ventilated survivors of COVID-19. American Journal of Respiratory and Critical Care Medicine. 2021; 203(3): 371-374. Available at: https://www.atsjournals.org/doi/10.1164/rccm.202010-3823LE

Smet J, Stylemans D, Hanon S, Verbanck S, Vanderhelst E, Ilsen B. Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection. Respiratory Medicine. 2021; 176: 106276. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701883/

Shah A, Wong A, Hague C, Murphy D, Johnston J, Ryerson C, et al. A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2021; 76(4): 402-404. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716339/

Lerum T, Aaløkken T, Brønstad E, Aarli B, Ikdahl E, Lund K, et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. European Respiratory Journal. 2021; 27(4): 2003448. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736755/

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2021; 397(10270): 220-232. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833295/

Zhong L, Zhang S, Wang J, Zhao X, Wang K, Ding W, et al. Analysis of Chest CT Results of Coronavirus Disease 2019 (COVID-19) Patients at First Follow-Up. Canadian Respiratory Journal. 2020; 2020. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643378/

Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time course of lung changes at chest CT during recovery from Coronavirus disease 2019 (COVID-19). Radiology. 2020; 295(3): 715-721. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233367/

Liu D, Zhang W, Pan F, Li L, Yang L, Zheng D, et al. The pulmonary sequalae in discharged patients with COVID-19: A short-term observational study. Respiratory Research. 2020; 21(1): 125. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245637/

Han X, Fan Y, Alwalid O, Jia X, Yuan M, Li Y, et al. Six-month follow-up chest CT findings after severe COVID-19 pneumonia. Radiology. 2021; 299(1): 177-186. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841877/

Guler S, Ebner L, Aubry-Beigelman C, Bridevaux P, Brutsche M, Clarenbach C, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. European Respiratory Journal. 2021; 57(4): 2003690. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082329/

Miwa M, Nakajima M, Kaszynski R, Hamada S, Ando H, Nakano T, et al. Abnormal pulmonary function and imaging studies in critical COVID-19 survivors at 100 days after the onset of symptoms. Respiratory Investigation. 2021. Available at: https://linkinghub.elsevier.com/retrieve/pii/S2212534521000861

Wang Y, Dong C, Hu Y, Li C, Ren Q, Zhang X, et al. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology. 2020; 296(2): 55-64. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233482/

Arnold D, Hamilton F, Milne A, Morley A, Viner J, Attwood M, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: Results from a prospective UK cohort. Thorax. 2021; 76(4): 399-401. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716340/

Published

2021-09-17

How to Cite

Mejía-Zambrano, H. (2021). Radiological and functional pulmonary complications in patients recovered from COVID-19. Microbes, Infection and Chemotherapy, 1, e1217. https://doi.org/10.54034/mic.e1217

Issue

Section

ORIGINAL RESEARCH